LOGAN CAROLYN J 4
4 · SALIX PHARMACEUTICALS LTD · Filed Jan 4, 2013
Insider Transaction Report
Form 4
LOGAN CAROLYN J
DirectorPresident & CEO
Transactions
- Tax Payment
Common Stock
2013-01-02$40.47/sh−22,268$901,186→ 613,613 total
Holdings
- 400,000(indirect: by GRAT)
Common Stock
- 44,000
Option to Buy Common Stock
Exercise: $17.63Exp: 2015-06-09→ Common Stock (44,000 underlying) - 33,750
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (33,750 underlying) - 65,625
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (65,625 underlying)
Footnotes (2)
- [F1]Represents shares forfeited to the company in connection with the satisfaction of tax liabilities incurred upon the annual vesting of restricted stock, and does not involve a sale of stock in the market.
- [F2]Options are 100% vested.